Antiarrhythmic drugs: past, present and future (Q35608800)

9 August 2017

1 reference

title

Antiarrhythmic drugs: past, present and future (English)

1 reference

9 August 2017

Dan M Roden

1

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Journal of Cardiovascular Electrophysiology

9 August 2017

published in

1 reference

9 August 2017

volume

14

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

1389-1396

1 reference

A structural basis for drug-induced long QT syndrome

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Molecular determinants of KCNQ1 channel block by a benzodiazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

The Brugada syndrome: clinical, electrophysiologic and genetic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

The Structure of the Potassium Channel: Molecular Basis of K+ Conduction and Selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

X-ray structure of a voltage-dependent K+ channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Pharmacogenomics: unlocking the human genome for better drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

The genetic basis of variability in drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

New advances in class III antiarrhythmic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

New ideas about atrial fibrillation 50 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Kb-R7943 prevents acute, atrial fibrillation-induced shortening of atrial refractoriness in anesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Are surrogate markers adequate to assess cardiovascular disease drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Mechanism of the cardiotoxic actions of terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.03441.X

10.1046/J.1540-8167.2003.03441.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference